Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Aston Sci, Astrazeneca, Biocytogen, Biontech, Daiichi Sankyo, Innocare, Moderna, Novavax, Pfizer, Pharmazz, Stemcyte, Tracon, United.